Further characterization of the best HTS compounds on cellular and functional assays indicated that an “old” drug, tebrophen ( Figure 1 ) can exhibit quite significant interactions with “new” targets, and that the compound can be classified as a “promising hit” for the anti-inflammatory/cancer therapeutic area.
1
—
—